Preferred dividend announcement puts MetLife’s income profile in focus

MetLife (MET) recently declared quarterly dividends across its preferred stock series, a routine income event that arrives as analysts highlight mixed signals around premium growth, book value trends, and the company’s adjusted earnings power.

The new preferred dividends come alongside commentary that points to softer net premiums earned compared with the broader insurance industry and slower book value per share expansion, while also emphasizing robust adjusted income and relatively low preferred payout ratios.

MetLife’s preferred dividend declaration comes as the stock trades at US$83.27, with a 30 day share price return of 7.17% and a 1 year total shareholder return of 8.53%. The 3 year total shareholder return of 76.57% points to stronger longer term momentum.

If you are weighing MetLife’s mix of income and growth, it can help to see how other income focused companies stack up, including those highlighted in our 10 dividend fortresses

With the stock trading below the average analyst price target and an intrinsic value estimate implying a sizable discount, the key question is whether this represents a genuine opportunity or whether the market already reflects MetLife’s future growth.

Most Popular Narrative: 6.8% Undervalued

MetLife’s most followed valuation narrative suggests a fair value of $89.31 versus the last close at $83.27, putting a modest discount in focus for investors assessing the preferred dividend news.

Strategic expansion of asset-light, fee-generating businesses (like employee benefits, asset management, and longevity reinsurance), combined with disciplined capital management, supports higher return on equity and more consistent, less capital-intensive earnings growth.

Want to see what is sitting behind that capital light earnings story? The narrative leans heavily on projected revenue growth, margin expansion, and a future profit multiple that only lines up if those assumptions hold together.

Result: Fair Value of $89.31 (UNDERVALUED)

However, keep in mind that weaker investment yields or credit losses on commercial mortgage loans could pressure earnings and test confidence in that capital-light story.

Another View: Multiples Signal A Richer Price Tag

While the narrative and intrinsic value work suggest upside, the plain P/E comparison tells a tighter story. MetLife trades on 15.6x earnings, which is higher than the US Insurance industry at 11.3x, the peer average at 13.7x, and the 14.7x fair ratio that the market could drift toward over time.

That gap points to less room for error, as the stock would need continued delivery on expectations to justify trading above industry, peers, and its own fair ratio. How comfortable are you with that trade off if sentiment shifts?

Next Steps

Mixed signals on value and income can make any stock feel like a close call, so consider reviewing the data yourself and weighing both sides with our breakdown of 3 key rewards and 1 important warning sign

Looking for more investment ideas?

If you stop with just one stock, you risk missing other opportunities that could fit your goals even better, so widen your list before you decide.

• Target long term compounding potential by scanning companies with attractive valuations and fundamentals using the 46 high quality undervalued stocks.
• Strengthen your income stream by reviewing stocks that offer robust yields and consistent payments in the 10 dividend fortresses.
• Reduce portfolio stress by focusing on businesses screened for resilience and lower risk profiles through the 65 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.